Stock A056090 INNOSYS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Innosys Co., Ltd.

Equities

A056090

KR7056090004

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-12 pm EDT 		5-day change 1st Jan Change
1,655 KRW +2.35% Intraday chart for Innosys Co., Ltd. +40.25% +40.25%
Feb. 13 Innosys Co., Ltd. announced that it has received KRW 10.00000001 billion in funding from CG Bio Co., Ltd. CI
Feb. 07 CG Bio Co., Ltd. completed the acquisition of Innosys Co., Ltd. from CG Bio Co., Ltd. CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 74,329 42,184 35,921 45,362 93,078 93,078
Enterprise Value (EV) 1 86,544 59,620 49,945 55,150 84,101 83,187
P/E ratio -4.96 x -22.3 x -2.79 x -8.82 x -4.23 x 57.1 x
Yield - - - - - -
Capitalization / Revenue 2.35 x 1.21 x 1.29 x 1.19 x 2.26 x 2.66 x
EV / Revenue 2.73 x 1.71 x 1.8 x 1.45 x 2.04 x 2.38 x
EV / EBITDA -41.3 x 54.2 x -5.95 x 40.9 x -10.5 x 20.5 x
EV / FCF -4.44 x -12.1 x 11.2 x 72 x -8.75 x -151 x
FCF Yield -22.5% -8.23% 8.93% 1.39% -11.4% -0.66%
Price to Book 1.87 x 1.11 x 1.33 x 1.59 x 1.61 x 1.55 x
Nbr of stocks (in thousands) 38,713 38,280 40,181 46,052 78,880 78,880
Reference price 2 1,920 1,102 894.0 985.0 1,180 1,180
Announcement Date 3/21/19 3/20/20 3/23/21 3/23/22 3/21/23 3/21/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 31,686 34,814 27,775 38,055 41,169 34,969
EBITDA 1 -2,096 1,100 -8,398 1,347 -7,977 4,057
EBIT 1 -4,929 -1,145 -10,805 -815.2 -10,177 2,204
Operating Margin -15.56% -3.29% -38.9% -2.14% -24.72% 6.3%
Earnings before Tax (EBT) 1 -15,913 -1,790 -12,108 -5,406 -18,421 1,387
Net income 1 -14,719 -1,890 -12,283 -4,970 -18,540 1,629
Net margin -46.45% -5.43% -44.22% -13.06% -45.03% 4.66%
EPS 2 -386.8 -49.45 -320.1 -111.7 -279.0 20.65
Free Cash Flow 1 -19,473 -4,908 4,459 766.1 -9,617 -549.6
FCF margin -61.46% -14.1% 16.05% 2.01% -23.36% -1.57%
FCF Conversion (EBITDA) - - - 56.86% - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/21/19 3/20/20 3/23/21 3/23/22 3/21/23 3/21/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 12,215 17,436 14,024 9,788 - -
Net Cash position 1 - - - - 8,977 9,892
Leverage (Debt/EBITDA) -5.828 x 15.85 x -1.67 x 7.265 x - -
Free Cash Flow 1 -19,473 -4,908 4,459 766 -9,617 -550
ROE (net income / shareholders' equity) -31.5% -4.9% -37.8% -18.7% -43.5% 2.22%
ROA (Net income/ Total Assets) -4% -0.98% -9.97% -0.73% -5.88% 1.25%
Assets 1 367,774 192,774 123,246 680,424 315,518 130,419
Book Value Per Share 2 1,027 992.0 674.0 620.0 732.0 763.0
Cash Flow per Share 2 288.0 101.0 127.0 268.0 285.0 160.0
Capex 1 15,368 711 205 862 820 1,590
Capex / Sales 48.5% 2.04% 0.74% 2.27% 1.99% 4.55%
Announcement Date 3/21/19 3/20/20 3/23/21 3/23/22 3/21/23 3/21/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Devices & Implants

1st Jan change Capi.
INNOSYS CO., LTD. Stock Innosys Co., Ltd.
+40.25% 113M
STRYKER CORPORATION Stock Stryker Corporation
+14.55% 131B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-7.43% 11.25B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
-10.14% 7.84B
GLAUKOS CORPORATION Stock Glaukos Corporation
+42.95% 5.72B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-17.77% 4.97B
AXONICS, INC. Stock Axonics, Inc.
+8.21% 3.44B
ENOVIS CORPORATION Stock Enovis Corporation
-19.83% 2.46B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-13.82% 2.02B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-15.84% 1.87B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. A056090 Stock
  4. Financials Innosys Co., Ltd.